Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
![Alex Azar](https://www.radiohc.cu/articles/3471-alex-azar-secretary.jpeg)
Related Articles
Commentaries
MAKE A COMMENT
All fields requiredMore Views
- Attorney General of Venezuela reports progress in investigation into sabotage of electrical system
- International rejection of Cuba's inclusion on Illegitimate U.S. list
- Cuban President Miguel Diaz-Canel, responding to shooting of Donald Trump, condemns all forms of violence
- Belarusian Ministry of Health grants registration to Cuban vaccine Cimavax
- Palestinian resistance accuses Argentinian president of justifying genocide in Gaza